PATENT CLAIM ANALYSIS

Application Number: 15866303
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "561000"]

Abstract:
The present disclosure provides co-crystals of a substituted glycine compound and a co-former compound of Formula (I): compositions comprising such, and uses thereof in treating and/or reducing the risk for a neuropsychiatric disorder (e.g., schizophrenia, psychotic disorders, depressive disorders, suicidal ideation and/or behavior, obsessive compulsive disorder or Alzheimer's disease). Also provided herein are methods for preparing the co-crystals.

Claim (Index 8):
The co-crystal of  claim 7 , wherein the co-former is D-tartaric acid, L-tartaric acid, or DL-tartaric acid.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 86.0
- Lexical Diversity: 1.35849
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15430750', '15188545', '14358606', '14799281', '14777018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7800392116765272
- 35 USC 102 Novelty (BERT): 0.5676287086455867
- Combined Prediction Score: 0.7587981613734331
- Mean Citation Score: 320.9926200000001
- Max Citation Score: 471.8377
- Similarity Product: 356.6140940882564

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test